Angiotensin (1-7): Mechanistic Insights and Benchmarks for Translational Research

Executive Summary: Angiotensin (1-7) (Ang-(1-7); Asp-Arg-Val-Tyr-Ile-His-Pro) is an endogenous heptapeptide hormone generated from angiotensin I or II by endo- or carboxy-peptidases (Oliveira et al., 2025). It acts as a selective agonist of the Mas receptor, modulating PI3K/AKT and ERK signaling pathways and influencing nitric oxide, FOXO1, and COX-2 production. Ang-(1-7) exerts anti-fibrotic and anti-inflammatory effects in multiple organ systems, supports metabolic homeostasis through enhanced glucose uptake and lipolysis, and provides cerebroprotection in ischemic stroke models (Mechanisms, Benchmarks, and Translation, 2023). Purity exceeds 99.7% (HPLC, MS), and the peptide is highly soluble in water and DMSO but not ethanol. Experimental protocols and benchmarks are robust and reproducible, with defined parameters for both in vitro and in vivo studies (APExBIO, A1041).

Biological Rationale

Angiotensin (1-7) is a central component of the non-classical renin-angiotensin system (RAS). It is produced from angiotensin I (1–10) or angiotensin II (1–8) via enzymatic cleavage by peptidases, including neprilysin and ACE2 (Oliveira et al., 2025). Unlike angiotensin II, which primarily promotes vasoconstriction and fibrosis via the AT1 receptor, Ang-(1-7) exerts vasodilatory, anti-fibrotic, anti-inflammatory, and anti-proliferative effects through the Mas receptor. This counter-regulatory axis is essential for maintaining cardiovascular, renal, and metabolic homeostasis (Mechanisms, Benchmarks, and Translation, 2023). Ang-(1-7) also modulates responses in the lungs, liver, kidney, CNS, and reproductive system, extending its impact beyond traditional RAS targets.

Mechanism of Action of Angiotensin (1-7)

Ang-(1-7) functions as a selective Mas receptor agonist. Upon binding, it activates several intracellular signaling cascades:

• PI3K/AKT Pathway: Promotes endothelial nitric oxide synthase (eNOS) activation and NO production, resulting in vasodilation and anti-inflammatory effects.
• ERK1/2 Pathway: Inhibits pro-fibrotic signaling and myofibroblast transition, notably in TGF-β-driven processes.
• FOXO1 and COX-2 Regulation: Modulates transcription factors and enzymes implicated in inflammation and metabolism.

Ang-(1-7) enhances glucose uptake, increases lipolysis, reduces insulin resistance, and ameliorates dyslipidemia. It also inhibits pathological angiogenesis, cell proliferation, and fibrosis in multiple tissues (APExBIO, A1041). In the CNS, Ang-(1-7) provides cerebroprotection, improves learning and memory, and may modulate neuroinflammation.

Evidence & Benchmarks

• Ang-(1-7) increases glucose uptake and lipolysis, reduces insulin resistance, and lowers dyslipidemia in metabolic disease models (Oliveira et al., 2025).
• Anti-fibrotic and anti-inflammatory actions are observed in lung, liver, and kidney models, with significant reduction in TGF-β-ERK pathway-mediated myofibroblast transition in rat kidney NRK-52E cells at 100 nM (APExBIO, A1041).
• Cerebroprotection is demonstrated in ischemic stroke models, with improved functional outcomes following Ang-(1-7) administration (Mechanisms, Benchmarks, and Translation, 2023).
• Daily intraperitoneal injection (0.01–0.06 mg/kg) in BALB/c mice ameliorates DSS-induced colitis by reducing phosphorylation of p38, ERK1/2, and Akt (APExBIO, A1041).
• Peptide purity is >99.7% by HPLC and MS analysis, ensuring experimental reproducibility (APExBIO, A1041).
• Ang-(1-7) modulates spike-AXL binding, highlighting a potential role in viral pathogenesis research (Oliveira et al., 2025).

Applications, Limits & Misconceptions

Angiotensin (1-7) is validated for:

• Cardiovascular and renal disease modeling, including hypertension, nephropathy, and fibrosis.
• Metabolic research for diabetes, obesity, and dyslipidemia.
• Neuroprotection and cognitive function studies.
• Oncology, as an anti-proliferative and anti-angiogenic agent.
• Reproductive system modulation (ovulation, spermatogenesis, steroid synthesis).
• Experimental models of inflammation, including DSS-induced colitis (APExBIO, A1041).

For a comprehensive workflow guide, see Angiotensin (1-7): Transforming Experimental Workflows (this article provides updated mechanistic detail and recent benchmarks compared to the cited guide). For renal and metabolic applications, Precision Applications in Renal & Metabolic Models focuses on protocol nuances, while this article adds new translational evidence and clarifies mechanistic boundaries.

Common Pitfalls or Misconceptions

• Ang-(1-7) is not a substitute for AT1R antagonists in all hypertensive models; distinct pathways are involved.
• Its effects are tissue-specific and may be absent or paradoxical in models lacking Mas receptor expression.
• Peptide is insoluble in ethanol; improper solvent choice leads to sample loss or aggregation.
• Long-term storage of reconstituted solutions (>1 week) is not recommended; peptide stability declines outside -20°C and desiccated conditions.
• Off-target effects may occur at supraphysiological concentrations; always follow recommended dosing.

Workflow Integration & Parameters

Angiotensin (1-7) from APExBIO (A1041) is supplied as a solid, with solubility of ≥48.5 mg/mL in water and ≥89.9 mg/mL in DMSO. It is insoluble in ethanol. Store desiccated at -20°C. Prepare fresh solutions for each experiment; avoid repeated freeze-thaw cycles.

Cell-based assays: Use 100 nM in rat kidney NRK-52E cells to inhibit TGF-β-ERK-driven myofibroblast transition; effects are reversible with the Mas antagonist A779 (APExBIO, A1041).

Animal models: Administer 0.01–0.06 mg/kg/day intraperitoneally in BALB/c mice for colitis and inflammation studies. Monitor endpoints including kinase phosphorylation (p38, ERK1/2, Akt) and clinical disease scores.

For advanced troubleshooting and design strategies, see Next-Generation Mechanistic Insights—this article adds explicit solubility and protocol parameters not detailed in the referenced analysis.

Conclusion & Outlook

Angiotensin (1-7) is a robust tool for dissecting Mas receptor-mediated signaling in diverse disease models. Its validated anti-fibrotic, anti-inflammatory, metabolic, neuroprotective, and anti-cancer effects make it indispensable for translational research. APExBIO provides high-purity Ang-(1-7) with rigorous quality control, supporting reproducible and high-impact studies (APExBIO, A1041). Ongoing research continues to refine its applications in viral pathogenesis and precision medicine.